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Introduction
Bone mineral density (BMD) is the result of a complex interaction
between genes and environmental factors. As a metric, it can be used
to identify osteoporosis, determine the risk of fracture, and measure
responses to treatments that affect bone remodeling. Previous
research has shown BMD to be highly heritable with genetic factors
accounting for approximately 50% to 85% of BMD (Özbaş, 2012).
Other anthropometric traits have similar genetic components:
heritability of lean body mass, for example, has been shown to be up
to 60-90% (Karasik & Kiel 2008). It is well established that muscle,
bone, and fat composition are all closely associated. Higher lean body
mass has been related to BMD and decreased fracture risk in elderly
men (Verchueren et al., 2013) and recent studies have shown that
increased lean mass and decreased fat mass raises BMD and reduces
fracture risk in post-menopausal women (Sotunde et al., 2015). As
novel single nucleotide polymorphisms (SNPs) influential for bone
development continue to be identified, it is important to determine
whether these SNPs have the same effect on musculoskeletal traits.
Zhang et al. (2014) performed a genome-wide association study
(GWAS) to identify which genes influenced BMD. This three stage
GWAS confirmed the genome-wide significance (GWS) of 13
previously reported loci and identified two novel loci at the GWS
level: rs227425 in the SPARC Related Modular Calcium Binding 1
gene (SMOC1) was significantly associated with BMD, and rs170183
in the claudin 14 (CLDN14) gene was also significantly associated
with BMD, though only among females.
The SMOC1 protein has been identified as an important contributor
to bone development and quality. Choi et al. (2010) discovered that
loss of SMOC1 results in inhibited mineralization and decreased
expression of osteoblast differentiation markers, while Okada et al.
(2011) determined SMOC1 expression to be essential for skeletal
formation, especially for limb development. CLDN14 regulates Ca2+
transport and paracellular permeability at epithelial tight junctions.
Knocking out CLDN14 leads to hypermagnesemia, hypomagnesiuria,
and hypocalciuria under increased Ca2+ intake conditions, implicating
a role for this gene in musculoskeletal functioning.
Prior studies have demonstrated that genetic variants located in the
SMOC1 and CLDN14 genes affect bone and limb development.
However, research has yet to incorporate these genes or their gene
products into the discussion of muscle-bone crosstalk and body
composition. Therein, the purpose of this study was to determine
whether these SNPs (rs170183 in the CLDN14 gene and rs227425 in
the SMOC1 gene) are associated with various musculoskeletal traits
in a cohort of African American children and a Caucasian young adult
cohort undergoing resistance training in the non-dominant arm.
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Experimental Design and Methods
Cohorts:
FAMuSS Cohort
The Functional Single Nucleotide Polymorphism Associated with Human Muscle Size and Strength (FAMuSS) study examined a cohort of
Caucasian young adults (mean age=24.5) who volunteered for a 12-week unilateral resistance training intervention of the non-dominant arm. At
entry and exit several traits were measured including 1-RM strength, maximum voluntary contraction (MVC) and whole muscle volume (pretraining, post-training, and % change). At entry and exit MRIs of both the dominant and non-dominant arm were analyzed for tissue volumetric
measures using modified RAPIDIA® software.
Bone Health Cohort
The Bone Health Cohort consists of 150 African American male and female participants who were enrolled at Children’s National Health System as
part of a fracture analysis study examining dietary intake of calcium and vitamin D and collecting various measurements of bone morphometry and
obesity. The cohort consists of 75 participants with a forearm fracture and 75 controls without any history of fracture ranging from five to nine years
of age. Measurements of participants’ total body-less head bone mineral density (tBMD), lumbar BMD (lBMD), total body-less head BMC
(tBMC), and lumbar BMC (lBMC) were obtained using a hologic dual-energy x-ray absorptiometry (DXA) scan. Exclusion criteria for the
study included underlying bone mineralization disorders, use of antiepileptic medications, current or past use of daily oral steroids for >1 month, or
a chronic illness that interacted with bone density such as sickle cell disease, cancer, kidney disease, malabsorptive disease, or cerebral palsy.
Genotyping:
Genomic DNA was extracted from whole blood samples using the PUREGENE DNA Purification System (Gentra Systems, Minneapolis, MN) per
manufacturer instructions. Genotypes were determined with TaqMan allelic discrimination assays via the 5’ nuclease activity of Taq polymerase to
detect a fluorescent reporter signal released during a PCR reaction. The final working solution for each SNP contained 3 L of DNA (2 ng/L) and 5
L of combined primers, probe, and Taqman® Universal PCR Master Mix (Life Technologies, Carlsbad, CA). PCR was performed on thermal
cyclers using a profile of 10 minutes at 95°C for denaturation, 44 cycles of 15 seconds at 95°C, and 1 minute at an annealing temperature of
60°C, followed by a brief cooling period. The post-PCR allele calling was completed using a Real Time PCR 7900HT (genotyping software SDS
version 2.4) and confirmed manually. Genotypes were determined by comparing the ratio of fluorescence signals (fluorophores: VIC/FAM).
Table 1
Allele Frequency by
Cohort
RS Number

Gene

Allele frequency
(1000genomes)

HWE pvalue

Location
Bone Health FAMuSS

• Across both sexes, rs170183 of the CLDN14 gene and rs227425 of the SMOC1 gene were both
associated with total body fat mass in the Bone Health cohort.
• Significant associations were discovered between muscle strength and rs170183 among females only in
the FAMuSS cohort. rs170183 also trended toward a significant association between genotype and change
in strength (% change in 1-RM strength) once more in female participants.
• While prior research shows no direct association between SMOC1 and total body fat mass, SMOCI is a
SPARC-related gene. Previous research suggests that VEGF, a signaling protein affected by SPARC,
does in fact affect body fat. This link makes further investigation of SMOC1 as it relates to the
development of body fat a promising future research direction.
• A 2014 GWAS identified that a SNP in the CLDN14 gene, rs170183, was associated with total hip,
lumbar spine, and femoral neck BMD in females (Zhang et al. 2014). In Zhang et al.’s (2014) study, the G
allele was associated with increased bone mineral density across all sites. Other studies have found that
the CLDN14 gene is associated with renal calcium handling and serum parathyroid hormone
(Thorleifsson, Gong).
• Our results support the sexually dimorphic effect of the rs170183 SNP as significant associations were
only found in the female population of the FAMuSS cohort.
• Thorleifsson et al. (2009) have also discovered an association between the CLDN14 gene and serum total
CO2 whereby individuals carrying one copy or more of the C allele of rs219780 experienced decreases in
total serum CO2 levels.
• Increased levels of CO2 lead to a decrease in blood pH (acidosis), with the resulting blood pH affecting
muscle performance. Skeletal muscle contraction occurs due to an increase in cytoplasmic Ca2+
concentrations, which causes Ca2+ to bind to troponin C, leading to the actin-myosin interaction
responsible for muscle performance (MacIntosh 2003). Therein, pH has been shown to modulate Ca2+
sensitivity: maximum force and Ca2+ permeability both decrease with a lowering of pH and acidosis is a
major contributor to muscle fatigue (MacIntosh 2003).
• As CLDN14 is associated with increased levels of CO2 which reduce blood pH, and maximum muscle
force and Ca2+ permeability are attenuated by a lowered pH, the link between rs170183 of the CLDN14
gene and maximum voluntary contraction (MVC) determined in this study becomes more relevant.

Bone
Health/
FAMuSS

AfricanAmerican

All

Discussion

Ca+2
permeability
CLDN14

Rs227425
Rs170183

Chr.14:
70456699
Chr.21:
CLDN14
37848334
SMOC1

T/G
(.53/.47)
G/A
(.86/.14)

T/G
(.51/.49)
A/G
(.52/.48)

T/G
(.53/.47)
A/G
(.36/.64)

G/T
(.65/.35)
G/A
(.95/.05)

0.22/0.90
0.06/0.09

Statistics:
A χ2-test was used to compare observed genotype frequencies to those expected under Hardy-Weinberg equilibrium (Table 1). All phenotypes were
assessed for normality using the Shapiro-Wilk test. In the Bone Health Cohort, genotypes were tested for associations with lean mass, fat mass, %
fat (all calculated by removing the head, as this skews results in pediatric populations), and physical activity measured by total hours of sun
exposure per week. The A allele of the CLDN14 SNP rs170183 is very rare in African Americans. Therefore, as the Bone Health Cohort consisted of
pediatric African Americans, we did not have any AA individuals with which to test associations. Phenotypes assessed in the Bone Health cohort
were analyzed with an ANCOVA (age and sex covariates), followed by post-hoc pair-wise comparisons to identify significance between individual
groups. SNPs were assessed for associations between genotype and 1- repetition max (1-RM) strength, maximum voluntary contraction (MVC) and
whole muscle volume (pre-training, post-training, and % change) in the FAMuSS cohort. The FAMuSS cohort was initially stratified by sex and
then significant associations were assessed using analysis of co-variance (ANCOVA) models with age and weight as covariates. All group analyses
that were significant were followed by post-hoc t-tests to determine individual group significance. Data are reported as means ± SEM or adjusted
means ± SEM where appropriate. Cutoff for significance was P <0.05.

Results
In the FAMuSS cohort, rs170183 was significantly associated with pre-exercise MVC strength (p=0.0100), post-exercise MVC strength
(p=0.0164), and % change in whole muscle volume (p=0.0413) in females. This SNP was also nearly significant in the % change in 1RM strength (p=0.0800) in female participants only (Table 2).

Low pH

Maximum Voluntary
Contraction
• The relationships among CLDN14, serum CO2, and maximum muscle force established in prior
research suggest that the association between rs170183 of the CLDN14 gene and maximum voluntary
contraction observed in this study is supported by the literature and promotes research regarding the
role of CLDN14 in muscle development.
• Since the SNPs investigated have not yet been linked to functional outcomes, this remains an area for
further study. Future studies may also want to further explore the association between rs17013 and MVC
seen in this study to better understand the mechanism behind this link, especially in light of the CLDN14
gene’s effect on CO2 levels. In addition, future studies may further investigate the sexual dimorphism
displayed in the effects of rs170183 on musculoskeletal traits.
• To our knowledge, this is the only study to associate these two SNPs with musculoskeletal traits other
than BMD.

In the Bone Health cohort, rs170183 (p=0.0600) and rs227425 (p=0.0419) were associated with total body fat mass across both sexes
(Table 3).
Table 2: Significant Associations in the Analysis of CLDN14 (rs170183) and SMOC1 (rs227425) in
the FAMuSS cohort
SNP

Phenotype

Group

P-value

CLDN14
(rs170183)

Pre-exercise MVC
strength (lbs.)

Females

0.0100

CLDN14
(rs170183)

Post-exercise MVC
strength (lbs.)

Females

0.0164

CLDN14
(rs170183)

Change in 1-RM
strength (%)

Females

0.0800

CLDN14
(rs170183)

Change in whole
muscle volume (%)

Females

0.0413

Genotype

N

Adjusted
mean ±
SEM

AA

106

69.4 ± 2.4

AG
GG
AA
AG
GG
AA
AG
GG
AA
AG
GG

201
94
106
201
94
107
198
97
73
139
67

62.7 ± 1.7*
70.8 ± 2.5*
85.4 ± 2.7*
76.6 ± 2.0*
83.5 ± 2.9
67.2 ± 3.5
67.0 ± 2.5
57.8 ± 3.5
11.6 ± 1.0
10.9 ± 0.7
8.3 ± 1.0

P-values for
individual
group
comparisons
*p=0.0238

*p=0.0265

NONE

NONE

Table 3: Significant Associations in the Analysis of CLDN14 (rs170183) and SMOC1 (rs227425) in
the Bone Health cohort
SNP

CLDN14
(rs170183)

SMOC1
(rs227425)

Phenotype

Total body fat mass (g)

Total body fat mass (g)

P-value

0.0600

0.0419

Adjusted
mean ±
SEM

P-values for
individual group
comparisons
NONE

Genotype

N

AA

0

GG

74

7699 ± 622

GA

27

9370 ± 865

GG

29

7735 ± 802

GT

51

9133 ± 714*

TT

20

6589 ± 991*

Figure 1: Image of a pediatric patient undergoing a DXA scan.
Source: http://pediatrics.med.miami.edu/crunchtime/facilities/dxa-laboratory
*p=0.0475

